Self-Organizing Nanovectors for Drug Delivery
Nanomedicine represents one of the most investigated areas in the last two decades in the field of pharmaceutics. Several nanovectors have been developed and a growing number of products have been approved. It is well known that many biomaterials are able to self-organize under controlled conditions...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_59186 | ||
| 005 | 20210212 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20210212s2020 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-03928-429-0 | ||
| 020 | |a 9783039284290 | ||
| 020 | |a 9783039284283 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-03928-429-0 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Matricardi, Pietro |4 auth | |
| 700 | 1 | |a De Rosa, Giuseppe |4 auth | |
| 245 | 1 | 0 | |a Self-Organizing Nanovectors for Drug Delivery |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 electronic resource (186 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Nanomedicine represents one of the most investigated areas in the last two decades in the field of pharmaceutics. Several nanovectors have been developed and a growing number of products have been approved. It is well known that many biomaterials are able to self-organize under controlled conditions giving rise nanostructures. Polymers, lipids, inorganic materials, peptides and proteins, and surfactants are examples of such biomaterials and the self-assembling property can be exploited to design nanovectors that are useful for drug delivery. The self-organization of nanostructures is an attractive approach to preparing nanovectors, avoiding complex and high-energy-consuming preparation methods, and, in some cases, facilitating drug loading procedures. Moreover, preparations based on these biocompatible and pharmaceutical grade biomaterials allow an easy transfer from the lab to the industrial scale. This book reports ten different works, and a review, aiming to cover multiple strategies and pharmaceutical applications in the field of self-organizing nanovectors for drug delivery. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a chitosan | ||
| 653 | |a encapsulation | ||
| 653 | |a gold nanoparticles | ||
| 653 | |a pH/redox-responsive | ||
| 653 | |a bolaform amphiphilic lipids | ||
| 653 | |a irradiation cycles | ||
| 653 | |a drug delivery | ||
| 653 | |a caries prevention | ||
| 653 | |a bolalipids | ||
| 653 | |a nanocage | ||
| 653 | |a natural extracts | ||
| 653 | |a astaxanthin | ||
| 653 | |a eukaryotic vaults | ||
| 653 | |a nanoparticles | ||
| 653 | |a amphiphilic random copolymers | ||
| 653 | |a zoledronic acid | ||
| 653 | |a triggered release | ||
| 653 | |a nanohydrogels | ||
| 653 | |a doxorubicin | ||
| 653 | |a vapor nanobubbles | ||
| 653 | |a curcumin | ||
| 653 | |a gold reduction | ||
| 653 | |a diffusion barrier | ||
| 653 | |a liposomes | ||
| 653 | |a hyaluronan | ||
| 653 | |a laser treatment | ||
| 653 | |a nanoparticle | ||
| 653 | |a mixed polymeric micelles | ||
| 653 | |a protein self-assembly | ||
| 653 | |a squalene | ||
| 653 | |a antimicrobial photodynamic therapy | ||
| 653 | |a self-assembly | ||
| 653 | |a hydrogel | ||
| 653 | |a C-peptide | ||
| 653 | |a polyelectrolyte complexes | ||
| 653 | |a siRNA delivery | ||
| 653 | |a drug delivery system | ||
| 653 | |a biofilms | ||
| 653 | |a pulmonary surfactant | ||
| 653 | |a multidrug resistance | ||
| 653 | |a drug delivery systems | ||
| 653 | |a nano-assemblies | ||
| 653 | |a photo-thermal therapy | ||
| 653 | |a anticancer | ||
| 653 | |a polypeptides | ||
| 653 | |a graphene quantum dots | ||
| 653 | |a nanovesicles | ||
| 653 | |a aerogel | ||
| 653 | |a resveratrol | ||
| 653 | |a intracellular therapy | ||
| 653 | |a Oral antimicrobials | ||
| 653 | |a syringeable implant | ||
| 653 | |a trehalose | ||
| 653 | |a betulinic acid | ||
| 653 | |a in situ gelling systems | ||
| 653 | |a autophagy induction | ||
| 653 | |a chorioallantoic membrane model | ||
| 653 | |a controlled release | ||
| 653 | |a diabetes | ||
| 653 | |a oxidative stress | ||
| 653 | |a localized heating effect | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2219 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/59186 |7 0 |z DOAB: description of the publication |